Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
RHHBY
Stock Latest News
Market News
Stock Market News Today, 7/19/24 – Indices Fall as Investors Rotate out of Megacaps
3d ago
AXP
CMA
Premium
The Fly
Genentech announces two-year data from Pagoda, Pavilion studies
4d ago
Premium
Press Releases
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
4d ago
Premium
The Fly
Relay Therapeutics price target lowered to $21 from $24 at JMP Securities
4d ago
RLAY
Premium
Market News
Eli Lilly (NYSE:LLY) Slides after New Weight Loss Competitor Emerges
5d ago
LLY
NVO
Premium
Press Releases
Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study
5d ago
Premium
The Fly
Roche announces new, four-year data from RHONE-X extension study
5d ago
Premium
The Fly
Roche obesity data read-throughs ‘may be a bit premature,’ says RBC Capital
5d ago
PFE
GILD
Premium
The Fly
Eli Lilly, Novo Nordisk slip after Roche reports weight loss pill data
5d ago
LLY
NVO
Premium
The Fly
Genentech announces results from two arms of CT-996 trial
5d ago
Premium
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity
6d ago
Premium
The Fly
Truist biotech analyst holds an analyst/industry conference call
11d ago
BMY
AMGN
Premium
The Fly
Arcus Biosciences price target lowered to $35 from $40 at Morgan Stanley
11d ago
MRK
GILD
Premium
The Fly
Arcus Biosciences price target lowered to $43 from $70 at BTIG
12d ago
RCUS
Premium
The Fly
Roche receives CE Mark for Accu-Chek SmartGuide CGM solution
13d ago
Premium
Press Releases
Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes
14d ago
Premium
Press Releases
Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)
14d ago
Premium
The Fly
Genentech to reintroduce Susvimo for people with Wet AMD
14d ago
Premium
The Fly
Arcus Biosciences drops 6% after Roche lung cancer failure
17d ago
GILD
RCUS
Premium
The Fly
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
17d ago
GILD
RCUS
Premium
The Fly
Genentech announces FDA approval of Vabysmo 6.0 mg single-dose prefilled syringe
17d ago
Premium
Press Releases
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss
18d ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
![[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2157214825-750x406.jpg)
